Glucagon analogue
Treatment of hypoglycemia in type 1 and type 2 diabetes patients
Target
GCGR [HSA:2642] [KO:K04583]
Pathway
hsa04080
Neuroactive ligand-receptor interaction
hsa04922
Glucagon signaling pathway
Brite
USP drug classification [BR:br08302]
Blood Glucose Regulators
Glycemic Agents
Dasiglucagon
D11359 Dasiglucagon (USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GCGR
D11359 Dasiglucagon (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11359
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11359